Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 34,199 | 27,940 | 24,758 | 25,866 | 22,561 |
| Gross Profit | 34,199 | 27,940 | 24,758 | 25,866 | 22,561 |
| Operating Expenses | 104,829 | 91,602 | 88,361 | 83,459 | 61,789 |
| Operating Income | -70,630 | -63,662 | -63,603 | -57,593 | -39,228 |
| Other Income | 180 | 149 | 137 | 189 | -6 |
| Pre-tax Income | -70,450 | -63,513 | -63,466 | -57,404 | -39,234 |
| Income Tax | 15 | 8 | 5 | -9 | 11 |
| Net Income Continuous | -70,465 | -63,521 | -63,471 | -57,395 | -39,245 |
| Net Income | $-70,465 | $-63,521 | $-63,471 | $-57,395 | $-39,245 |
| EPS Basic Total Ops | -1.16 | -1.05 | -1.05 | -0.97 | -0.66 |
| EPS Basic Continuous Ops | -1.16 | -1.05 | -1.05 | -0.97 | -0.66 |
| EPS Diluted Total Ops | -1.16 | -1.05 | -1.05 | -0.97 | -0.66 |
| EPS Diluted Continuous Ops | -1.16 | -1.05 | -1.05 | -0.97 | -0.66 |
| EPS Diluted Before Non-Recurring Items | -1.14 | -1.05 | -1.03 | -0.95 | -0.66 |
| EBITDA(a) | $-69,470 | $-62,626 | $-62,577 | $-56,589 | $-38,325 |